REVIEW
|
doi:10.20944/preprints202306.1176.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
lung cancer; organoid; drug screening; high throughput; translational; pre-clinical; clinical; tumor microenvironment; personalized medicine
Online: 16 June 2023 (08:42:28 CEST)